APA (7th ed.) Citation

Wang, X., Cao, D., Hu, Q., Chen, Y., & Luo, T. Optimum duration of adjuvant trastuzumab in treatment of human epidermal growth factor receptor-2 positive early breast cancer: Protocol for a network meta-analysis of randomised controlled trials. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Wang, Xin, Dan Cao, Qiancheng Hu, Ye Chen, and Ting Luo. Optimum Duration of Adjuvant Trastuzumab in Treatment of Human Epidermal Growth Factor Receptor-2 Positive Early Breast Cancer: Protocol for a Network Meta-analysis of Randomised Controlled Trials. BMJ Publishing Group.

MLA (9th ed.) Citation

Wang, Xin, et al. Optimum Duration of Adjuvant Trastuzumab in Treatment of Human Epidermal Growth Factor Receptor-2 Positive Early Breast Cancer: Protocol for a Network Meta-analysis of Randomised Controlled Trials. BMJ Publishing Group.